Bristol-Myers Squibb Company PFD CONV 2 (BMYMP)
USD 875.0
(0.0%)
USD 875.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 17.24 Billion USD | 66.94% |
| 2022 | 10.32 Billion USD | 1.66% |
| 2021 | 10.15 Billion USD | 98.11% |
| 2020 | 5.12 Billion USD | -6.15% |
| 2019 | 5.46 Billion USD | 6.76% |
| 2018 | 5.11 Billion USD | 48.35% |
| 2017 | 3.45 Billion USD | -23.99% |
| 2016 | 4.53 Billion USD | 162.37% |
| 2015 | 1.73 Billion USD | 0.93% |
| 2014 | 1.71 Billion USD | -41.52% |
| 2013 | 2.93 Billion USD | -25.46% |
| 2012 | 3.93 Billion USD | -40.85% |
| 2011 | 6.64 Billion USD | 17.13% |
| 2010 | 5.67 Billion USD | -1.1% |
| 2009 | 5.73 Billion USD | 35.3% |
| 2008 | 4.24 Billion USD | 20.21% |
| 2007 | 3.52 Billion USD | 34.61% |
| 2006 | 2.62 Billion USD | -33.66% |
| 2005 | 3.95 Billion USD | -11.49% |
| 2004 | 4.46 Billion USD | -9.76% |
| 2003 | 4.94 Billion USD | 15.18% |
| 2002 | 4.29 Billion USD | -31.31% |
| 2001 | 6.25 Billion USD | 4.46% |
| 2000 | 5.98 Billion USD | 2.27% |
| 1999 | 5.85 Billion USD | 14.29% |
| 1998 | 5.12 Billion USD | 15.39% |
| 1997 | 4.43 Billion USD | 12.27% |
| 1996 | 3.95 Billion USD | 9.35% |
| 1995 | 3.61 Billion USD | 12.23% |
| 1994 | 3.22 Billion USD | 34.04% |
| 1993 | 2.4 Billion USD | 22.6% |
| 1992 | 1.96 Billion USD | -29.14% |
| 1991 | 2.76 Billion USD | 15.78% |
| 1990 | 2.38 Billion USD | 120.59% |
| 1989 | 1.08 Billion USD | -38.81% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 4.57 Billion USD | -15.94% |
| 2024 Q2 | 2.58 Billion USD | 14.18% |
| 2024 Q1 | 2.26 Billion USD | 34.38% |
| 2023 Q4 | 1.68 Billion USD | -60.05% |
| 2023 Q2 | 4.15 Billion USD | 46.41% |
| 2023 FY | 17.24 Billion USD | 66.94% |
| 2023 Q1 | 2.84 Billion USD | 19.78% |
| 2023 Q3 | 4.21 Billion USD | 1.37% |
| 2022 Q2 | 2.8 Billion USD | 12.52% |
| 2022 Q4 | 2.37 Billion USD | -12.61% |
| 2022 FY | 10.32 Billion USD | 1.66% |
| 2022 Q1 | 2.49 Billion USD | 14.26% |
| 2022 Q3 | 2.71 Billion USD | -3.25% |
| 2021 Q3 | 1.74 Billion USD | 12.7% |
| 2021 Q4 | 2.18 Billion USD | 24.77% |
| 2021 FY | 10.15 Billion USD | 98.11% |
| 2021 Q1 | 1.82 Billion USD | 317.88% |
| 2021 Q2 | 1.55 Billion USD | -15.15% |
| 2020 Q2 | 891 Million USD | 13.79% |
| 2020 FY | 5.12 Billion USD | -6.15% |
| 2020 Q1 | 783 Million USD | 40.57% |
| 2020 Q3 | 1.34 Billion USD | 50.62% |
| 2020 Q4 | -839 Million USD | -162.52% |
| 2019 Q4 | 557 Million USD | -68.35% |
| 2019 Q3 | 1.76 Billion USD | -6.23% |
| 2019 Q2 | 1.87 Billion USD | 9.19% |
| 2019 Q1 | 1.71 Billion USD | 9.7% |
| 2019 FY | 5.46 Billion USD | 6.76% |
| 2018 Q1 | 1.37 Billion USD | 184.33% |
| 2018 Q2 | 513 Million USD | -62.8% |
| 2018 Q3 | 1.65 Billion USD | 223.39% |
| 2018 Q4 | 1.56 Billion USD | -5.55% |
| 2018 FY | 5.11 Billion USD | 48.35% |
| 2017 Q2 | 720 Million USD | -43.53% |
| 2017 FY | 3.45 Billion USD | -23.99% |
| 2017 Q1 | 1.27 Billion USD | 30.9% |
| 2017 Q3 | 970 Million USD | 34.72% |
| 2017 Q4 | 485 Million USD | -50.0% |
| 2016 Q4 | 974 Million USD | -25.99% |
| 2016 FY | 4.53 Billion USD | 162.37% |
| 2016 Q1 | 1.11 Billion USD | 949.62% |
| 2016 Q2 | 1.13 Billion USD | 2.07% |
| 2016 Q3 | 1.31 Billion USD | 15.85% |
| 2015 Q2 | 123 Million USD | -89.04% |
| 2015 Q4 | -131 Million USD | -121.27% |
| 2015 Q1 | 1.12 Billion USD | 112300.0% |
| 2015 FY | 1.73 Billion USD | 0.93% |
| 2015 Q3 | 616 Million USD | 400.81% |
| 2014 Q2 | 299 Million USD | -58.06% |
| 2014 Q1 | 713 Million USD | -17.29% |
| 2014 FY | 1.71 Billion USD | -41.52% |
| 2014 Q4 | -1 Million USD | -100.14% |
| 2014 Q3 | 703 Million USD | 135.12% |
| 2013 Q3 | 786 Million USD | 25.16% |
| 2013 Q4 | 862 Million USD | 9.67% |
| 2013 Q2 | 628 Million USD | -4.12% |
| 2013 Q1 | 655 Million USD | 25.72% |
| 2013 FY | 2.93 Billion USD | -25.46% |
| 2012 Q1 | 2.01 Billion USD | 27.69% |
| 2012 FY | 3.93 Billion USD | -40.85% |
| 2012 Q4 | 521 Million USD | -6.96% |
| 2012 Q3 | 560 Million USD | -44.44% |
| 2012 Q2 | 1 Billion USD | -49.98% |
| 2011 Q1 | 1.59 Billion USD | 40.18% |
| 2011 FY | 6.64 Billion USD | 17.13% |
| 2011 Q4 | 1.57 Billion USD | -9.36% |
| 2011 Q3 | 1.74 Billion USD | 0.23% |
| 2011 Q2 | 1.73 Billion USD | 9.18% |
| 2010 FY | 5.67 Billion USD | -1.1% |
| 2010 Q4 | 1.13 Billion USD | -27.75% |
| 2010 Q3 | 1.57 Billion USD | 3.9% |
| 2010 Q2 | 1.51 Billion USD | 2.23% |
| 2010 Q1 | 1.47 Billion USD | 87.69% |
| 2009 FY | 5.73 Billion USD | 35.3% |
| 2009 Q4 | 788 Million USD | -55.68% |
| 2009 Q3 | 1.77 Billion USD | -0.61% |
| 2009 Q1 | 1.29 Billion USD | 58.02% |
| 2009 Q2 | 1.78 Billion USD | 38.57% |
| 2008 Q1 | 1.17 Billion USD | 90.29% |
| 2008 FY | 4.24 Billion USD | 20.21% |
| 2008 Q3 | 1.21 Billion USD | 8.38% |
| 2008 Q4 | 817 Million USD | -32.81% |
| 2008 Q2 | 1.12 Billion USD | -4.59% |
| 2007 Q3 | 1.03 Billion USD | 1.17% |
| 2007 Q1 | 850 Million USD | 293.52% |
| 2007 FY | 3.52 Billion USD | 34.61% |
| 2007 Q2 | 1.02 Billion USD | 20.47% |
| 2007 Q4 | 618 Million USD | -40.35% |
| 2006 FY | 2.62 Billion USD | -33.66% |
| 2006 Q4 | 216 Million USD | -52.84% |
| 2006 Q3 | 458 Million USD | -55.53% |
| 2006 Q2 | 1.03 Billion USD | 12.32% |
| 2006 Q1 | 917 Million USD | 9.69% |
| 2005 Q1 | 1.01 Billion USD | 2.64% |
| 2005 Q2 | 1.12 Billion USD | 11.18% |
| 2005 FY | 3.95 Billion USD | -11.49% |
| 2005 Q3 | 980 Million USD | -12.81% |
| 2005 Q4 | 836 Million USD | -14.69% |
| 2004 FY | 4.46 Billion USD | -9.76% |
| 2004 Q1 | 1.14 Billion USD | -2.21% |
| 2004 Q2 | 1.15 Billion USD | 0.26% |
| 2004 Q3 | 1.17 Billion USD | 2.26% |
| 2004 Q4 | 985 Million USD | -16.38% |
| 2003 Q1 | 1.15 Billion USD | 30.84% |
| 2003 Q2 | 1.25 Billion USD | 8.32% |
| 2003 Q3 | 1.36 Billion USD | 9.44% |
| 2003 FY | 4.94 Billion USD | 15.18% |
| 2003 Q4 | 1.17 Billion USD | -14.11% |
| 2002 Q2 | 790 Million USD | -20.6% |
| 2002 Q1 | 995 Million USD | -32.17% |
| 2002 Q3 | 1.07 Billion USD | 36.08% |
| 2002 FY | 4.29 Billion USD | -31.31% |
| 2002 Q4 | 882 Million USD | -17.95% |
| 2001 Q2 | 1.5 Billion USD | -11.03% |
| 2001 FY | 6.25 Billion USD | 4.46% |
| 2001 Q4 | 1.46 Billion USD | -12.42% |
| 2001 Q3 | 1.67 Billion USD | 11.59% |
| 2001 Q1 | 1.68 Billion USD | 5.04% |
| 2000 Q4 | 1.6 Billion USD | 5.17% |
| 2000 Q1 | 1.67 Billion USD | 8.89% |
| 2000 FY | 5.98 Billion USD | 2.27% |
| 2000 Q2 | 1.49 Billion USD | -10.67% |
| 2000 Q3 | 1.52 Billion USD | 1.87% |
| 1999 Q3 | 1.51 Billion USD | 15.17% |
| 1999 Q1 | 1.47 Billion USD | 11.9% |
| 1999 Q2 | 1.31 Billion USD | -10.7% |
| 1999 Q4 | 1.54 Billion USD | 1.52% |
| 1999 FY | 5.85 Billion USD | 14.29% |
| 1998 Q2 | 1.16 Billion USD | -9.91% |
| 1998 Q4 | 1.31 Billion USD | -2.01% |
| 1998 FY | 5.12 Billion USD | 15.39% |
| 1998 Q1 | 1.29 Billion USD | 19.96% |
| 1998 Q3 | 1.34 Billion USD | 15.64% |
| 1997 Q4 | 1.07 Billion USD | -9.95% |
| 1997 FY | 4.43 Billion USD | 12.27% |
| 1997 Q3 | 1.19 Billion USD | 15.89% |
| 1997 Q1 | 1.13 Billion USD | 19.51% |
| 1997 Q2 | 1.03 Billion USD | -8.91% |
| 1996 Q1 | 1.02 Billion USD | 18.42% |
| 1996 FY | 3.95 Billion USD | 9.35% |
| 1996 Q4 | 948 Million USD | -10.57% |
| 1996 Q3 | 1.06 Billion USD | 14.84% |
| 1996 Q2 | 923 Million USD | -9.69% |
| 1995 Q2 | 862 Million USD | -7.51% |
| 1995 Q4 | 863 Million USD | -9.92% |
| 1995 Q3 | 958 Million USD | 11.14% |
| 1995 Q1 | 932 Million USD | 24.6% |
| 1995 FY | 3.61 Billion USD | 12.23% |
| 1994 Q2 | 772 Million USD | -6.76% |
| 1994 Q1 | 828 Million USD | 744.9% |
| 1994 Q3 | 874 Million USD | 13.21% |
| 1994 Q4 | 748 Million USD | -14.42% |
| 1994 FY | 3.22 Billion USD | 34.04% |
| 1993 Q4 | 98 Million USD | -88.09% |
| 1993 Q3 | 823 Million USD | 16.9% |
| 1993 Q1 | 778 Million USD | 390.3% |
| 1993 Q2 | 704 Million USD | -9.51% |
| 1993 FY | 2.4 Billion USD | 22.6% |
| 1992 Q1 | 751 Million USD | 28.82% |
| 1992 Q3 | 808 Million USD | 20.78% |
| 1992 Q4 | -268 Million USD | -133.17% |
| 1992 FY | 1.96 Billion USD | -29.14% |
| 1992 Q2 | 669 Million USD | -10.92% |
| 1991 Q4 | 583 Million USD | -25.64% |
| 1991 Q1 | 704 Million USD | 49.15% |
| 1991 Q3 | 784 Million USD | 12.81% |
| 1991 Q2 | 695 Million USD | -1.28% |
| 1991 FY | 2.76 Billion USD | 15.78% |
| 1990 Q3 | 716 Million USD | 18.15% |
| 1990 Q2 | 606 Million USD | 1.85% |
| 1990 Q1 | 595 Million USD | 110.36% |
| 1990 FY | 2.38 Billion USD | 120.59% |
| 1990 Q4 | 472 Million USD | -34.08% |
| 1989 Q4 | -5.74 Billion USD | -347.67% |
| 1989 Q3 | 2.32 Billion USD | 3.39% |
| 1989 FY | 1.08 Billion USD | -38.81% |
| 1989 Q1 | 2.26 Billion USD | 148.77% |
| 1989 Q2 | 2.24 Billion USD | -0.93% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AstraZeneca PLC | 8.19 Billion USD | -110.448% |
| CSPC Pharmaceutical Group Limited | 7.01 Billion USD | -145.752% |
| Clarus Therapeutics Holdings, Inc. | -39.73 Million USD | 43495.752% |
| Novartis AG | 9.76 Billion USD | -76.497% |
| PT Kalbe Farma Tbk. | 3625.13 Billion USD | 99.524% |